Microsaic Systems plc Appointment of Interim Chairman (9812U)
24 January 2017 - 11:56PM
UK Regulatory
TIDMMSYS
RNS Number : 9812U
Microsaic Systems plc
24 January 2017
24 January 2017
Microsaic Systems plc
("Microsaic", "Microsaic Systems" or the "Company")
Appointment of Interim Chairman
Microsaic Systems plc (AIM: MSYS), the developer of chip-based
mass spectrometry instruments, announces that it has appointed
Prof. Eric Yeatman as Interim Chairman of the Board while the
Company continues its search for a successor to Mr Colin Nicholl
who retires as Chairman on 31 January 2017. Prof. Yeatman is an
experienced chair, having previously held the position for nine
years, resigning on 1 July 2013. Since 1 July 2013, he has been a
Non-Executive Director of the Company.
The process to recruit a new Chairman is progressing, and
discussions have been held with a number of potential candidates.
The Company will keep shareholders updated on the recruitment
process.
Separately, Mr Christopher Buckley, Non-Executive Director, will
join the Remuneration Committee and Finance and Audit
Committee.
Enquiries:
Microsaic Systems plc
Jim Ramage, CEO
Bevan Metcalf, FD +44 (0) 1483 751577
N+1 Singer (Nominated Adviser
& Broker)
Shaun Dobson
Liz Yong +44 (0)20 7496 3000
Citigate Dewe Rogerson
(Financial PR)
Mark Swallow, Marine Perrier +44 (0)20 7282 2948/1068
About Microsaic Systems
Microsaic Systems plc is a high technology company developing
chip-based, bench-top mass spectrometry ("MS") instruments that are
designed to improve the efficiency of Pharma R&D. MS is an
analytical technique of choice for biochemists across many industry
sectors.
Microsaic aims to bring routine MS analysis to the
pharmaceutical scientist, providing powerful methods of analysis to
enable earlier decision making relating to product identification,
purity and bioactivity.
The Company is working with established global companies in
preparative and purification science with expertise in Pharma and
life sciences to co-develop new, integrated and optimised,
application-specific, solutions to improve productivity in the
development of small molecule and novel biologic (peptides,
antibodies) medicines.
The Microsaic 4000 MiD(R), single quadrupole, is the world's
smallest MS system, retaining the functionality of larger
conventional MS systems, is easier to use by non-specialists,
consumes less energy and has lower running costs. The Company is
also developing new MS systems, based on its patented chip
technologies, to address further areas of emerging need in Pharma
R&D.
Microsaic Systems was established in 2001 by a team including
founders from Imperial College London, and was admitted to AIM in
2011 (ticker: MSYS).
www.microsaic.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAPGUAAGUPMGPC
(END) Dow Jones Newswires
January 24, 2017 07:56 ET (12:56 GMT)
Microsaic Systems (LSE:MSYS)
Historical Stock Chart
From Apr 2024 to May 2024
Microsaic Systems (LSE:MSYS)
Historical Stock Chart
From May 2023 to May 2024